Condition: Pediatric Migraine · Sponsor: Pfizer
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.
This description comes directly from the study's public registry record.
Pfizer Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Achieve Clinical Research, LLC d/b/a Accel Research Sites-Neurology and Neurodiagnostic of Alabama | Birmingham, Alabama, United States | Active Not Recruiting |
| Perseverance Research Center, LLC | Scottsdale, Arizona, United States | Recruiting |
| Physicians Research Group | Tempe, Arizona, United States | Active Not Recruiting |
| Advanced Research Center, Inc. | Anaheim, California, United States | Recruiting |
| Adult & Child Neurology Medical Associates | Costa Mesa, California, United States | Recruiting |
| ProScience Research Group | Culver City, California, United States | Active Not Recruiting |
| Memorial Health Services | Fountain Valley, California, United States | Recruiting |
| Neuro-Pain Research Center | Fresno, California, United States | Recruiting |
| Altman Clinical and Translational Research Institute, University of California San Diego | La Jolla, California, United States | Recruiting |
| Adult & Child Neurology Medical Associates | Long Beach, California, United States | Recruiting |
| Miller Children's & Women's Hospital Long Beach | Long Beach, California, United States | Recruiting |
| National Research Institute | Los Angeles, California, United States | Active Not Recruiting |
+ 234 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04649242